For the development of VEXAS syndrome and acquisition of the UBA1 mutation in patients with JAK2V617F mutation or other driver mutations, it is currently unknown when the time course of these events occurs in relation to the development of fulminant phenotypic disease. The gene discussed is UBA1; the disease is VEXAS syndrome.